Immunovant, Inc.
IMVT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001764013
In the last 90 days, Immunovant, Inc. insiders filed 0 open-market purchases and 10 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.25B in total; Greenlight Capital is the only superinvestor holding it.
13F holders, Q2 2021
Institutional positions in Immunovant, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 110
- −10 vs. Q1 2021
- Shares held
- 38.6M
- −1.89M (−4.7%) vs. Q1 2021
- Total value
- $407.5M
- −$246.8M (−37.7%) vs. Q1 2021
- New holders
- 21
- 45 more added
- Sold out
- 31
- 31 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMVT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 226 | $4.25B |
| Q1 2026 | 216 | $2.75B |
| Q4 2025 | 197 | $2.76B |
| Q3 2025 | 186 | $1.53B |
| Q2 2025 | 169 | $1.54B |
| Q1 2025 | 194 | $1.62B |
| Q4 2024 | 187 | $1.98B |
| Q3 2024 | 182 | $2.26B |
| Q2 2024 | 197 | $1.97B |
| Q1 2024 | 209 | $2.27B |
| Q4 2023 | 228 | $2.88B |
| Q3 2023 | 181 | $2.57B |
| Q2 2023 | 147 | $1.05B |
| Q1 2023 | 142 | $903.7M |
| Q4 2022 | 133 | $1.00B |
| Q3 2022 | 112 | $238.1M |
| Q2 2022 | 94 | $156.5M |
| Q1 2022 | 112 | $218.6M |
| Q4 2021 | 118 | $322.4M |
| Q3 2021 | 119 | $293.6M |
| Q2 2021 | 110 | $407.5M |
| Q1 2021 | 120 | $654.3M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Immunovant, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Boxer Capital, LLC | 1,000,000 | $10.6M | 0.37% | 00.0% | Unchanged |
| BVF Inc | 1,273,516 | $13.5M | 0.50% | +129,500+11.3% | Added |
| Two Sigma Investments, LP | 1,275,149 | $13.5M | 0.04% | +504,584+65.5% | Added |
| Morgan Stanley | 1,542,372 | $16.3M | 0.00% | +789,721+104.9% | Added |
| Alpine Global Management, LLC | 2,000,000 | $21.1M | 2.88% | +903,022+82.3% | Added |
| BlackRock Inc. | 3,102,787 | $32.8M | 0.00% | −582,229−15.8% | Reduced |
| Eventide Asset Management, LLC | 3,370,994 | $35.6M | 0.48% | +897,994+36.3% | Added |
| Woodline Partners LP | 3,750,575 | $39.6M | 0.74% | +2,853,958+318.3% | Added |
| Vanguard Group Inc | 4,000,697 | $42.3M | 0.00% | +3,977+0.1% | Added |
| State Street Corp | 4,390,637 | $46.4M | 0.00% | +774,877+21.4% | Added |
| RTW Investments, LP | 0 | $0 | 0.00% | −6,356,743−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −181,749−100.0% | Sold out |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −467,000−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −377,309−100.0% | Sold out |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −337,048−100.0% | Sold out |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −260,000−100.0% | Sold out |
| Ghost Tree Capital, LLC | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −187,900−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −158,500−100.0% | Sold out |
| Brookfield Asset Management Inc. | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −90,479−100.0% | Sold out |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −77,000−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −68,937−100.0% | Sold out |
| Darwin Global Management, Ltd. | 0 | $0 | 0.00% | −65,849−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −50,400−100.0% | Sold out |
| Foresite Capital Management V, LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| AlphaCrest Capital Management LLC | 0 | $0 | 0.00% | −39,200−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −25,254−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −25,119−100.0% | Sold out |
| Moore Capital Management, LP | 0 | $0 | 0.00% | −24,113−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −18,114−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −14,800−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −13,880−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −13,620−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −8,600−100.0% | Sold out |
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −6,092−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −4,594−100.0% | Sold out |
| SG3 Management, LLC | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −1,815−100.0% | Sold out |
| Alpha DNA Investment Management LLC | 0 | $0 | 0.00% | −193−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −26−100.0% | Sold out |